Product ID | L6015 |
Name | ASKENDOSIDE D |
Molecular formula | C45H74O17 |
Description |
It is a cardiac glycoside used in treatment of cardiac failure. Glycoside , from Astragalus taschkendicus of the Leguminosae family. |
Biological activity | Askendoside D presents a high selectivity for the cardiac Na+/K+-ATPase, with practically no activity on brain or kidney Na+/K+-ATPases, as compared with other cardiac glycosides (unpublished). |
Packaging | Price (€) | Quantité | Buy Now |
---|---|---|---|
10 mg | 112.00 | ||
50 mg | 448.00 | ||
For quotation of big quantities, please Contact us |
Safety Data Sheet Available on request, please Contact us Ref. SDS_L6015 : unit price : free of charge |
Product code | L6015 | Molecular weight | 887.1 g/mol |
Product name | ASKENDOSIDE D | Physical form | Powder |
CAS No. | 86408-17-5 | Melting point | 235-236 °C |
RTECS | Solubility | In DMSO, pyridine Not well in water and alcohol. |
|
UNIPROT | Optical Activity | [alpha]D20 -9.1° ± 2° (c = 1.1 in pyridine) | |
PubChem SID | 103476520 | ||
PubChem CID | 21630099 | ||
Purity | 99.99 % (TLC, mass spectrometry, NMR) | ||
Toxicity(LD50) | IPR-RAT LD0: no mortality at 1 000 mg/kg | ||
Chemical Name | (2S,3R,4S,5R)-2-[[(1S,3R,6S,8R,9S,11S,12S,14S,15R,16R)-6-[(2S,3R,4S,5R)-4,5-dihydroxy-3-[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-14-hydroxy-15-[(2R,5S)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethyl-9-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]oxy]oxane-3,4,5-triol | ||
Storage & Reconstitution Recommandations |
Store at +4°C, in dark place. |
||
Savety Recommandations | For research use only — not intended for food, diagnostic or therapeutic use |
Product code | L6015 |
Product name | ASKENDOSIDE D |
Product code | L6015 |
Product name | ASKENDOSIDE D |
External Links | PubMed |
Biomedical Citations From PubMed | |
Toxicology Citations From PubMed | |
PubChem SID | |
PubChem CID | |